Heart Failure (ch 121)

• Congestive heart failure (CHF) risks
• CHF typical presentation
• NYHA Classification of CHF
• AHA/ACC 2009 - staging system of heart
• HFrEF stands for
• HFpEF stands for
• HFmrEF stands for
• CHF Diagnosis orders
• CHF treatment & management
• CHF treatment & management : ACE targets
• CHF treatment & management : Beta blocker targets
• **CHF treatment & management : 2016 guidelines**
• ARNI - ARB combined w neprilysin
• Other management guidelines for CHF
• Top 10 challenges of CHF management

High Cholesterol ( ch 211)

• Hyperlipidemia LDL-C (mg/dL)
• Triglycerides (mg/dL) HDL-C
• 10-year ASCVD risk (IB) assessment
• Lifetime ASCVD risk assessment
• Other tests of value for ASCVD assessment
• Lifestyle recommendations forASCVD prevention
• TLC for hyperlipidemia ; Nutrition
• Exercise recommendations for hyperlipidemia/BP
• Primary prevention for ASCVD; Statin Medications
• Secondary prevention for ASCVD; Statin Medications
• What do you assess prior to starting Statin therapy
• Common secondary causes of hyperlipidemia
• Complimentary medicine for hypercholesterolemia
• Co-enzyme Q 10 doses
• interpret labs and ASCVD risk assessment:

HTN- (ch 122)

• Define hypertension, both systolic and diastolic
• Differentiate between:
• Discuss the prevalence of primary and secondary hypertension in this country
• Discuss the procedure for obtaining an accurate blood pressure
• Compare office blood pressure to ambulatory blood pressure monitoring and home monitoring in the diagnosis and treatment of hypertension
• Outline and explain each portion of the work-up for the patient with primary and secondary hypertension. Include important aspects of:
• Formulate treatment goals for hypertension
• Manage the treatment of hypertension including lifestyle modification and pharmacologic therapy based on the JNC 7 algorithm
• Describe the following for Thiazide-diuretics:
• Describe the following for Beta-Blockers:
• Describe the following for Ca Channel Blockers:
• Describe the following for ACE-Inhibitors:
• Describe the following for Aldosterone antagonists:
• Discuss the use of Osteopathic Manipulation in the treatment of hypertension
• Outline follow-up visits for the treatment of hypertension
• What are causes of secondary hypertension? (hint ABCDE)
• Define hypertension for children and adolescents
• Discuss the relationship between BP & CVD
• What specific questions should you ask during the history?
• What specific questions should you ask during the review of systems?
• What specifically should you look at when performing a physical exam on a pt whom you suspect has HTN
• Describe what lab and diagnostic tests would be useful to determine cause of secondary hypertension?
• Describe recommended lifestyle modifications
• Error! Filename not specified.
• Discuss the treatment of hypertension in special groups such as:
• Describe the favorable outcomes for drug considerations in treatment of HTN
• Describe the unfavorable outcomes for drug considerations in treatment of HTN
• Define resistant hypertension     
• List possible reasons for resistant hypertension
• Discuss patient compliance for treatment of HTN
• Differentiate secondary causes of hypertension based of clinical presentation:
• Discuss the treatment of hypertension in special groups such as:

MI- ( ch 120)

• Types of MI
• Anterior wall MI
• Septal Wall MI
• lateral wall MI
• Inferior wall MI
• RV infarction
• Symptoms of MI
• 5 components of Pain Assessment
• Diagnositc Test for MI
• Tx and *N intervention for MI
• Drug therapy for MI
• Additional *N care for MI
• Discharge planning for MI

PE (pulmonary embolism)  

• Define PE: Pulmonary Embolus.
• What does it reduce?
• What do the effects produce?
• Blockage of pulmonary arteries by thrombus, fat or air embolus, or tumor tissue and Obstructs alveolar perfusion is what condition?                                                  
• Pulmonary embolism most commonly affect what lobes?            
• What are risk factors for pulmonary embolism?
• What is the most common symptom of pulmonary embolism(PE)?                   
• S/S of PE are dependent on size and extent of?              
• Alveolar necrosis and hemorrhage, Abscess, and Pleural effusion are s/s is from what complication that can happen from PE?                 
• What complication from PE Results from hypoxemia associated with massive or recurrent emboli and Right ventricular hypertrophy?           
• What diagnostic study for PE gets Elevated with any clot degradation and False negatives with small PE?
• What diagnostic test is used most frequently for dx test and requires IV contrast media?
• What diagnostic test is used if pt can't have contrast?
• What diagnostic test is the most sensitive but invasive?
• ______ is key for PE?
• Collaborative care for PE:
• Goals of treatment for PE:
• Examples of supportive care for PE?
• Examples of fibrinolytic agents used for PE?
• What surgical therapy should be used for a massive PE?
• What surgical therapy prevents migration of clots in pulmonary system?
• Nursing management for PE:
• What should a nurse teach to a pt with PE?

• Evaluation: